Showing results (1771-1780 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|August 10, 2012
MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancerCaroline Poli, Caroline Raffin, Danijel Dojcinovic, et al.Haematologica|August 10, 2012
Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphomaAndrew Hodson, Daniel J Laydon, Barbara J Bain, et al.Haematologica|August 18, 2012
Histone acetylation and DNA demethylation of T cells result in an anaplastic large cell lymphoma-like phenotypeMaria Joosten, Volkhard Seitz, Karin Zimmermann, et al.Haematologica|November 14, 2022
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patientsSpyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, et al.Haematologica|March 23, 2023
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMTRaynier Devillier, Dirk-Jan Eikema, Carlo Dufour, et al.Haematologica|March 23, 2023
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabineSarit Assouline, Jadwiga Gasiorek, Julie Bergeron, et al.Haematologica|March 2, 2023
PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplantMelissa Thomas, Junan Li, Kevan King, et al.Haematologica|August 11, 2022
Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300Franziska Hettler, Christina Schreck, Sandra Romero Marquez, et al.Haematologica|August 11, 2022
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapySusanna Carolina Berger, Boris Fehse, Nuray Akyüz, et al.Haematologica|June 20, 2020
Acquired von Willebrand syndrome: focused for hematologistsMassimo Franchini, Pier Mannuccio MannucciPageof 816